BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26

• Business

  Sevion Therapeutics Announces Chimerasome Research Agreement

  November 24, 2014

   · 

  1 min read
• Policy

  Merck & Co. Submits New Drug Application To The Japanese Pharmaceuticals And Medical Devices Agency For Omarigliptin, An Investigational Once-Weekly DPP-4 Inhibitor For Type 2 Diabetes

  November 24, 2014

   · 

  4 min read
• Genetown

  Ora-CAC® Model Provided Platform For Recent Positive Phase 2 Data For Ocular Therapeutix, Inc.’s OTX-DP In Allergic Conjunctivitis

  November 24, 2014

   · 

  4 min read
• Policy

  IGI Laboratories, Inc. Announces ANDA Submission

  November 24, 2014

   · 

  2 min read
• Drug Development

  Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment

  November 24, 2014

   · 

  4 min read
• Policy

  Apotex Inc. Sues Health Canada Over An ‘Unlawful’ Ban On Its Drugs

  November 24, 2014

   · 

  1 min read
• Business

  Kevin M. Smith To Retire As President & CEO Of The Colorado Institute For Drug, Device And Diagnostic Development; Search Committee Formed To Hire Smith’s Successor

  November 24, 2014

   · 

  3 min read
• Business

  3D Systems And Cimatron Enter Definitive Agreement For 3D Systems To Acquire Cimatron

  November 24, 2014

   · 

  9 min read
• Nanjing Frontier Biotech In-licenses Novel Patch Pain Product

  November 24, 2014

   · 

  1 min read
• Business

  PerkinElmer, Inc. Enters Into Definitive Agreement To Acquire Perten Instruments

  November 24, 2014

   · 

  5 min read